Publication | Closed Access

Supplementation of folic acid and vitamin B12 reduces plasma levels of asymmetric dimethylarginine in patients with acute ischemic stroke

Cerebrovascular DiseaseCerebral Vascular RegulationThrombosisNeurologyPublic HealthAtherosclerosisIschemic SyndromeMedicineVitamin B ComplexCerebral Blood FlowReperfusion InjuryPharmacologyVitamin NutritionCardiovascular DiseaseIschemic StrokeVitamin B12Stroke-related ConditionFolic AcidStrokeAsymmetric Dimethylarginine